Morgan Jess S & CO Inc Bristol Myers Squibb CO Transaction History

Morgan Jess S & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Nov 30, 2021	SELL	$61.91 - $67.42 $3.28 Million - $3.57 Million	-53,024 Closed	0 $0
Q1 2021 Nov 30, 2021	BUY	$59.34 - $66.74 $78,328 - $88,096	1,320 Added 2.55%	53,024 $3.35 Million
Q4 2020 Nov 30, 2021	BUY	$57.74 - $65.43 $632,830 - $717,112	10,960 Added 26.9%	51,704 $3.21 Million
Q3 2020 Nov 29, 2021	BUY	$57.43 - $63.64 $32,160 - $35,638	560 Added 1.39%	40,744 $2.46 Million
Q2 2020 Nov 29, 2021	SELL	$54.82 - $64.09 $285,995 - $334,357	-5,217 Reduced 11.49%	40,184 $2.36 Million
Q1 2020 Nov 29, 2021	BUY	$46.4 - $67.43 $842,856 - $1.22 Million	18,165 Added 66.69%	45,401 $2.53 Million
Q4 2019 Nov 19, 2021	BUY	$49.21 - $64.19 $1.34 Million - $1.75 Million	27,236 New	27,236 $1.75 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgan Jess S & CO Inc with notifications on news.